Cash and the California Stem Cell Agency: A Critique Notes August Deadline for New Funding Initiative
California's $3 billion stem cell program is facing a cash crunch this year, and the latest commentary on its financial fate raises a host of questions.
The critique comes from the Center for Genetics and Society, a Berkeley group that has long been critical of the California Institute for Regenerative Medicine (CIRM), as the state stem cell agency is k…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.